BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein.EBI
University of Toronto Mississauga
Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.EBI
University of Toronto
Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors.EBI
Astrazeneca R&D Boston
SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.EBI
University of Michigan
Kinetic Target-Guided Synthesis: Reaching the Age of Maturity.EBI
Univ. Lille
A small-molecule screen identifies the antitrypanosomal agent suramin and analogues NF023 and NF449 as inhibitors of STAT5a/b.EBI
Leipzig University
Halogen-substituted catechol bisphosphates are potent and selective inhibitors of the transcription factor STAT5b.EBI
Leipzig University